Erica Darian-Smith
Contact Info
Office Hours
- Today
- 8:00AM-5:00PM
Erica Darian-Smith
About Erica Darian-Smith
Dr. Darian-Smith received a Bachelor of Medicine/ Bachelor of Surgery from the University of Tasmania, where she graduated with clinical distinction. She went on to complete a Master of Medicine as well as a Graduate Diploma in Refractive Surgery at the University of Sydney. She is currently a Research Doctorate Candidate at the Prince of Wales Hospital Ophthalmology Clinical School at the University of New South Wales.
Dr. Darian-Smith is currently a Refractive Fellow in Toronto. She previously worked as an ophthalmologist at the Prince of Wales Hospital in New South Wales, Australia. She was also a private operating assistant at several hospitals, including Westmead Private, Royal Prince Alfred Day Surgery, and Save Sight Foundation Sydney Eye Hospital, where she assisted in a mixture of vision correction procedures.
Dr. Darian-Smith previously completed medical residencies at Sydney Eye Hospital, Royal Prince Alfred Hospital, and The Alfred Hospital. She also interned at Sir Charles Gairdner Hospital (SCGH) in Perth, Western Australia.
Dr. Darian-Smith was a recipient of the 2022 ASCRS Foundation Resident Excellence Award. In 2019, she was awarded the RANZCO Filipic Greer Medal for overall excellence in performance at the RANZCO Ophthalmic Pathology examination. She was also a nominee for the Charles Gairdner Hospital’s 2015 Schneider Prize, which is presented to the intern who demonstrates the greatest care and compassion in the practice of medicine.
As an accomplished researcher, Dr. Darian-Smith’s work has been featured in numerous journals, including the American Journal of Ophthalmology, the Journal of Cataract and Refractive Surgery, the European Journal of Ophthalmology, and Clinical and Experimental Ophthalmology. She’s also had the opportunity to present her research at various international conferences. Dr. Darian-Smith was previously appointed as an associate lecturer in the discipline of ophthalmology at the University of New South Wales and the University of Sydney.
Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Important Safety Information
The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.